Potential Novel Schizophrenia Treatments

A comprehensive discussion on new treatment options for patients with schizophrenia, highlighting the potential for earlier intervention to optimize treatment outcomes.

EP: 1.Burden, Stigma, and Prevalence of Schizophrenia

EP: 2.Exploration into the Management of the Three Symptom Domains of Schizophrenia

EP: 3.Insights on the Pathophysiology of Schizophrenia

EP: 4.Physician Awareness of Cognitive Dysfunction in Schizophrenia

Now Viewing

EP: 5.Potential Novel Schizophrenia Treatments

EP: 6.Future Perspectives on Schizophrenia Care

Related Videos

Related Content

Advertisement

March 12th 2025

Managing Catatonia: A Case Report From Rural South Africa

Grace Lehnerdt, MD

September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD

March 7th 2025

Tragic or Treated: Why We Cannot Miss Postpartum Psychosis

Meghan Cliffel Susan Hatters Friedman, MD, MSt, DFAPA

May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD

February 28th 2025

Learning How to Actively Listen: In Conversation With Stephen McLeod-Bryant, MD

Leah Kuntz Stephen McLeod-Bryant, MD

February 25th 2025

FDA Officially Removes REMS Requirement for Clozapine

Heidi Anne Duerr, MPH

Related Content

Advertisement

March 12th 2025

Managing Catatonia: A Case Report From Rural South Africa

Grace Lehnerdt, MD

September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD

March 7th 2025

Tragic or Treated: Why We Cannot Miss Postpartum Psychosis

Meghan Cliffel Susan Hatters Friedman, MD, MSt, DFAPA

May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD

February 28th 2025

Learning How to Actively Listen: In Conversation With Stephen McLeod-Bryant, MD

Leah Kuntz Stephen McLeod-Bryant, MD

February 25th 2025

FDA Officially Removes REMS Requirement for Clozapine

Heidi Anne Duerr, MPH